Business
Bluebird Bio Stock Is in Free Fall
[ad_1] Two weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for…
[ad_1] Two weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for…
[ad_1] Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share…